These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification, virtual screening and molecular dynamic analysis of novel TMPRSS2 inhibitors from natural compound database as potential entry-blocking agents in SARS-CoV-2 therapy. Manandhar S; Pai KSR; Krishnamurthy PT; Kiran AVVVR; Kumari GK Struct Chem; 2022; 33(5):1609-1617. PubMed ID: 35754942 [TBL] [Abstract][Full Text] [Related]
3. Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target. DurdaĞi S Turk J Biol; 2020; 44(3):185-191. PubMed ID: 32595355 [TBL] [Abstract][Full Text] [Related]
5. Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages. Singh N; Decroly E; Khatib AM; Villoutreix BO Eur J Pharm Sci; 2020 Oct; 153():105495. PubMed ID: 32730844 [TBL] [Abstract][Full Text] [Related]
6. Screening strategy of TMPRSS2 inhibitors by FRET-based enzymatic activity for TMPRSS2-based cancer and COVID-19 treatment. Chen Y; Huang WC; Yang CS; Cheng FJ; Chiu YF; Chen HF; Huynh TK; Huang CF; Chen CH; Wang HC; Hung MC Am J Cancer Res; 2021; 11(3):827-836. PubMed ID: 33791156 [TBL] [Abstract][Full Text] [Related]
7. Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies. Elbadwi FA; Khairy EA; Alsamani FO; Mahadi MA; Abdalrahman SE; Ahmed ZAM; Elsayed I; Ibraheem W; Alzain AA Inform Med Unlocked; 2021; 26():100725. PubMed ID: 34514079 [TBL] [Abstract][Full Text] [Related]
8. Targeting mechanism for SARS-CoV-2 Zhao X; Luo S; Huang K; Xiong D; Zhang JZH; Duan L Nanoscale; 2021 Nov; 13(45):19218-19237. PubMed ID: 34787160 [TBL] [Abstract][Full Text] [Related]
9. In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19. Esam Z; Akhavan M; Lotfi M; Pourmand S; Bekhradnia A Chem Zvesti; 2023; 77(2):1129-1148. PubMed ID: 36312321 [TBL] [Abstract][Full Text] [Related]
12. Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post-translational modification: a multiple target approach. Singh R; Gautam A; Chandel S; Sharma V; Ghosh A; Dey D; Roy S; Ravichandiran V; Ghosh D In Silico Pharmacol; 2021; 9(1):27. PubMed ID: 33842191 [TBL] [Abstract][Full Text] [Related]
13. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery. Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429 [TBL] [Abstract][Full Text] [Related]
16. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Kumar Y; Singh H; Patel CN J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274 [TBL] [Abstract][Full Text] [Related]
17. Identification of some dietary flavonoids as potential inhibitors of TMPRSS2 through protein-ligand interaction studies and binding free energy calculations. Varughese JK; J K; S SK; Francis D; L JLK; G AT Struct Chem; 2022; 33(5):1489-1502. PubMed ID: 35645548 [TBL] [Abstract][Full Text] [Related]
18. Discovery of novel TMPRSS2 inhibitors for COVID-19 using Alzain AA; Elbadwi FA; Alsamani FO Inform Med Unlocked; 2022; 29():100870. PubMed ID: 35128036 [TBL] [Abstract][Full Text] [Related]
19. Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19. Hu X; Shrimp JH; Guo H; Xu M; Chen CZ; Zhu W; Zakharov AV; Jain S; Shinn P; Simeonov A; Hall MD; Shen M ACS Pharmacol Transl Sci; 2021 Jun; 4(3):1124-1135. PubMed ID: 34136758 [TBL] [Abstract][Full Text] [Related]
20. Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease. Wang SC; Chen Y; Wang YC; Wang WJ; Yang CS; Tsai CL; Hou MH; Chen HF; Shen YC; Hung MC Am J Cancer Res; 2020; 10(12):4538-4546. PubMed ID: 33415017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]